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Brief Communications
-Adrenergic Blockade during Memory Retrieval in Humans
Evokes a Sustained Reduction of Declarative Emotional
Memory Enhancement
Marijn C. W. Kroes,1,2 Bryan A. Strange,1 and Raymond J. Dolan1
1Wellcome Trust Centre for Neuroimaging, Institute of Neurology, LondonWC1N 3BG, United Kingdom, and 2Donders Institute for Brain, Cognition and
Behavior, Centre for Cognitive Neuroimaging, Radboud University, 6500 HB Nijmegen, The Netherlands
Memory enhancement for emotional events is dependent on amygdala activation and noradrenergic modulation during learning. A
potential role for noradrenaline (NE) during retrieval of emotional memory is less well understood. Here, we report that administration
of the -adrenergic receptor antagonist propranolol at retrieval abolishes a declarative memory enhancement for emotional items.
Critically, this effect persists at a subsequent 24 h memory test, in the absence of propranolol. Thus, these findings extend our current
understanding of the role of NE in emotionalmemory to encompass effects at retrieval, and provide face validity to clinical interventions
using -adrenergic antagonists in conjunction with reactivation of unwanted memories in anxiety-related disorders.
Introduction
Enhanced episodic memory for emotional events (Christianson,
1992; Cahill et al., 1995) is dependent on the amygdala (LeDoux,
2000). During initial acquisition or consolidation of an emo-
tional memory, the amygdala is thought to upregulate neuronal
processing in the hippocampus (McGaugh et al., 2002; Richardson
et al., 2004) through a -adrenergic mechanism (Cahill and
McGaugh, 1998; McGaugh, 2004; Strange and Dolan, 2004).
-Adrenergic blockade with the 12-antagonist propranolol se-
lectively impairs long-term human episodic memory for emo-
tionally arousing material without affecting memory for neutral
material when administered before learning (Cahill et al., 1994;
Strange et al., 2003). This widely accepted model of noradren-
ergic influences on human emotional memory, by focusing on
encoding and consolidation (Cahill and McGaugh, 1998), im-
plicitly suggests that the role of noradrenaline (NE) does not
extend to retrieval of emotional memories. Providing evidence
for a role of NE in retrieval would therefore add considerably to a
broader understanding of the nature of emotional influences on
memory.
Although adaptive to survival, emotional memory enhance-
ment may also have pathological consequences, as in anxiety-
related disorders such as post-traumatic stress disorder (PTSD)
(Ressler and Mayberg, 2007). Once consolidated, memories are
thought to be relatively insensitive to disruption or additional
modulation (McGaugh, 2000), rendering pharmacological treat-
ments long after the traumatic event therapeutically ineffective.
However, if neuromodulatory effects on emotionalmemory after
consolidation were evident, then this would provide a potential
therapeutic approach for attenuating the retrieval of unwanted,
established, emotional memories. As such, the application of NE
antagonists might, for example, reduce the occurrence of intru-
sive memories such as flashbacks in PTSD. Identifying a role for
NE during emotional memory retrieval would therefore be of
considerable clinical significance.
Currently, the role of NE at retrieval is unclear. Human brain
imaging during emotional memory retrieval demonstrates acti-
vation of the locus ceruleus (LC) (Sterpenich et al., 2006), the
origin of noradrenergic forebrain projections (Pickel et al., 1974;
Fallon et al., 1978). Other studies demonstrate amygdala engage-
ment during similar emotional memory retrieval tasks (Maratos
et al., 2001; Smith et al., 2004, 2006). However, human psycho-
pharmacological data fail to demonstrate blockade of enhanced
emotional retrieval by propranolol given at recall (deQuervain et
al., 2007; Tollenaar et al., 2009). This contrasts with observations
in rodents that propranolol, given before retrieval of contextual
conditioned fear, attenuates the fear response (Murchison et al.,
2004). One possible explanation for this discrepancy is that the
memory paradigm used in previous human studies (de Quervain
et al., 2007; Tollenaar et al., 2009) did not evoke a robust emo-
tional memory enhancement. Thus, the absence of consistent
and robust emotional memory enhancements in these studies
indicates a relatively marginal contribution of the adrenergic sys-
tem in these tasks, such that an effect of propranolol could not
be detected. Therefore, we conducted a double-blind, placebo-
controlled experiment testing the effect of propranolol on cued
recall of emotionally aversive verbal stimuli, using a stimulus set
known to cause amarked emotionalmemory enhancement effect
that is also known to be dependent on the amygdala and NE
(Strange et al., 2003; Strange and Dolan, 2004).
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Briefly, on day 1 subjects encoded neu-
tral control nouns (C) with occasional
nouns being emotionally aversive (E
nouns) or perceptually distinct (P nouns)
(Strange et al., 2003) (Fig. 1A). On day 2,
subjects were administered either pro-
pranolol (40 mg) or placebo and 90 min
later engaged in a cued-recall test (Fig.
1B). To rule out the possibility that any
modulation of emotional memory re-
trieval by propranolol is restricted to test-
ing in the presence of drug, we again
tested subjects 24 h later, in the absence of
placebo or drug, using the cued-recall test.
We demonstrate enhanced memory for E
relative to C nouns in the placebo group
on both day 2 and day 3. Administration
of propranolol at retrieval abolishes emo-
tional memory enhancement on day 2, an
effect that is present at least 24 h later on
day 3.
Materials andMethods
Twenty-four right-handed native English speak-
ers with normal/corrected to normal vision,
without cardiorespiratory, neurological, or
psychiatric history participated in the study.
The placebo and propranolol groups each
comprised 12 subjects, 7 males and 5 females,
respectively, with a mean age of 24.4 years
(range, 19–34). One male subject in the pro-
pranolol group only completed day 1 and day 2
of the experiment. All subjects gave informed consent, and the study had
full ethics approval. The experiment was conducted on 3 consecutive
days, with each session at the same time of day and in the same testing
room for a given subject.
Day 1. Blood pressure (BP) was measured and an electrocardiogram
acquired for each participant on arrival. During encoding, subjects
viewed 360 nouns presented visually in uppercase at a rate of one noun
every 3 s (stimulus duration, 1 s). The nouns consisted of 300 neutral
nouns all presented in the same font, 30 nouns were emotionally aversive
oddballs (E), presented in the same font as the neutral nouns, and 30
nounswere perceptual oddballs (P), presented in different fonts. E nouns
were selected from the set used in our previous studies (Strange et al.,
2003; Richardson et al., 2004). Subjects engaged in a deep encoding task
(Craik and Lockhart, 1972), making a push button response to indicate
whether the noun described a living or nonliving entity. Although we
have previously shown emotional memory enhancement to be more
pronounced after shallow encoding (Strange et al., 2003), a deep encod-
ing task was chosen to ensure adequate memory performance on day 2
and day 3. Word presentation was randomized and oddballs were ran-
domly presented after four to six (mean, five) neutral words.Words were
“stem-unique” in that the first three letters were different for each of the
360 words. A total of 120 words served as controls (C), with the con-
straint that these controls were more than one word before or after a
given oddball.
Day 2. BP was again measured and subjects were then administered
either an oral dose of 40 mg of propranolol or placebo (vitamin C) in a
double-blind experimental design. After 80 min, subjects filled out the
State form of the State-Trait Anxiety Inventory (STAIS) (Spielberger et
al., 1983) and the BeckDepression Inventory-II (BDI) (Beck et al., 1996).
Subjects then performed a surprise memory task on the words encoded
on day 1. In view of the kinetics of the peak plasma concentration (1–2 h)
of propranolol, the memory task started 90 min after drug administra-
tion. Randomly selected word stems (first three letters) for 240 of the 360
nouns encoded on day 1 were presented visually in uppercase in random
order. Of these, 200 were neutral, 20 were emotional oddballs, and 20
were perceptual oddballs. All nouns were presented in the same font,
including nouns that were perceptually distinct on day 1 (i.e., P nouns).
Subjects were instructed to complete the stems to make a word encoded
on day 1. Presentation of stimuli was continuous and stems were pre-
sented every 4 s with a stimulus duration of 1 s.We used a cued-recall test
of retrieval to increase recall performance from a large study list.
Day 3. This followed the same procedure as day 2 except that no drug
was administered on day 3. Furthermore, 360 stems were presented; the
240 presented on day 2 plus stems pertaining to the remaining 100 neu-
tral words, 10 emotional oddballs, and 10 perceptual oddballs from day 1
that had not been presented on day 2.
Results
Propranolol did not affect cued recall of control nouns (Fig. 2A).
A group (“placebo”; “propranolol”) by day (day 2; day 3) 2 2
repeated-measures ANOVA on C noun recall revealed no main
effects of group (F(1,10)  0.706; p  0.420) or day (F(1,10) 
2.124; p  0.176) and no group by day interaction (F(1,10) 
0.381; p  0.551). No memory enhancement was detected for
perceptual oddballs (see supplemental material, available at
www.jneurosci.org), and as such remaining analyses were re-
stricted to emotional versus neutral nouns. Importantly, recall
performance for all words was significantly above chance as in-
dicated in a separate experimental baseline cue completion group
(see supplemental material, available at www.jneurosci.org).
In our critical comparison, we tested for the effect of drug
manipulation on E noun memory relative to subject-specific C
noun recall (Fig. 2A). A group (placebo; propranolol) by day (day
2; day 3) by noun type (emotional; control) 2 2 2 repeated-
measures ANOVA revealed a significant main effect of group
(F(1,10) 9.491; p 0.012) and noun type (F(1,10) 8.461; p
0.016), and a significant group by noun type interaction (F(1,10)
A
B
Figure 1. Experimental design. A, Depiction of the encoding task (left) and cued-recall task (right). During encoding, stem-
unique nouns are presented with occasional emotional nouns (E) and perceptually distinct nouns (P). During the cued-recall task,
three letter stems of the nouns encoded on the first day are presented. The stems of the perceptual nouns are not presented in a
distinct font. B, Schematic of the study design over 3 d. Note that propranolol is only administered on day 2. BP, Blood pressure
measurement.
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13.174; p  0.005), with no other significant main effects or
interactions.
Planned comparisons confirmed that, on day 2, the placebo
group showed enhanced recall for emotional nouns relative to
control nouns (t(11) 5.365; p 0.001, two-tailed), whereas no
emotional memory enhancement was evident in the propranolol
group (t(11) 1.044; p 0.319, two-tailed) (Fig. 2B). On day 3,
the placebo group continued to show enhanced recall for emo-
tional relative to control nouns (t(11)  2.702; p  0.021, two-
tailed). Critically, subjects who had received propranolol on the
previous day persist in showing an absent emotional memory
enhancement on day 3 (t(11)  0.202; p  0.844, two-tailed)
(Fig. 2B). Directly comparing E noun recall between the placebo
and propranolol group revealed reduced memory scores for the
propranolol group on day 2 (t(22) 2.900; p 0.008, two-tailed)
and on day 3 (t(21)  2.701; p  0.013, two-tailed). In both
groups, the E nouns remembered on day 2 tended to be the same
as those remembered on day 3 (see supplemental Results, Fig. S1,
available at www.jneurosci.org as supplemental material).
Cued-recall performance for perceptual nouns, as well as for
nouns cued only on day 3, is given in supplemental Fig. S2 (avail-
able at www.jneurosci.org as supplemental material). For the
items that had not been presented on day 2, drug manipulation
did not affect mean recall of control nouns on day 3 (t(21) 
1.177; p  0.255, two-tailed). Critically, no recall differences
between the drug groups were found for the new emotional
nouns (t(21) 0.153; p 0.880, two-tailed).
On day 2, there was no baseline systolic BP differences be-
tween groups (t(21)0.223; p 0.826, two-tailed). In line with
previous findings (Tollenaar et al., 2009), we observe a drop in
systolic BP in the propranolol group (t(20)  1.842; p  0.04,
one-tailed) after 90 min, but no drop in diastolic BP (Fig. 2C).
Note that at both time points BP measurements for a different
placebo subject was lost because of equipment failure.
Discussion
Ourdataprovideacleardemonstrationof a critical role forNE in the
retrieval of emotional memory. We show that -adrenergic block-
ade by propranolol at retrieval abolishes the declarative memory
enhancement for emotional items. Second, we show that 24 h after
-adrenergic blockade at retrieval, a sustained reduction of emo-
tional item recall is still observed in a second retrieval test in the
absence of propranolol. Our findings provide support for the possi-
bility of lasting attenuation of emotional memory in therapeutic
contexts by pharmacological interventions at retrieval.
Our finding of a role for NE in retrieval of emotional memory
speaks directly to the discrepancy between neuroimaging data,
which implicate the NE system in emotional memory retrieval
(Sterpenich et al., 2006), and human psychopharmacological
studies, which report no effect of propranolol administration at
retrieval on the enhancing effect of emotion on memory (de
Quervain et al., 2007; Tollenaar et al., 2009). The latter negative
findings might be explained by an absence of robust memory
enhancement for emotional items in these tasks, possibly because
of the presentation of equal numbers of neutral and emotional
items and/or the presentation of emotional items of both positive
and negative valence (Tollenaar et al., 2009). The use of equal
numbers of emotional and neutral items in these previous studies
may have resulted in rapid amygdala habituation (Fischer et al.,
2003), attenuating the memory enhancement process. In the
oddball task used here, the amygdala response to emotional items
has been shown not to habituate over repeated exposure (Strange
and Dolan, 2001). Furthermore, valence can enhance memory
for low-arousing items via prefrontal-based organizational strat-
egies during retrieval that are independent of the amygdala
and noradrenergic modulation (Kensinger and Corkin, 2004;
Mickley Steinmetz and Kensinger, 2009). Indeed, we note a sug-
gestion (Tollenaar et al., 2009) that a lack of an effect of propran-
ololmight be attributable to a nondependence of their task on the
amygdala and/or NE.
B
A
C
Figure 2. Propranolol at retrieval causes a sustained reduction of emotional memory en-
hancement. A, Cued recall (percentage hits) on day 2 (top) and day 3 (bottom) of emotional
nouns (E) (gray) and control nouns (C) for the placebo (left column) and propranolol (right
column) groups. Drugmanipulation before retrieval on day 2 causes a significant reduction of E
relative to C recall on day 2, which is sustained on day 3 in the absence of drug. B, Cued recall
(percentage hits) of emotional nouns minus subject-specific control noun recall on day 2 and
day 3 for the placebo (left column) and propranolol (right column) groups. C, Systolic (Sy) and
diastolic (Di) BP (in millimeters mercury) before placebo (left column) or propranolol (right
column) administration (0 min) and after 90 min. No baseline difference in systolic or diastolic
BP is present between groups. The propranolol group displays a significant reduction in systolic
BP 90 min after application. Error bars indicate SEM. **p 0.001, two-tailed; *p 0.05,
two-tailed; Fp 0.05, one-tailed.
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Animal data indicate that a role for NE in emotional memory
retrieval is time specific. Emotional memory retrieval is affected
by noradrenergic manipulation at 2 h, but not 1 h, after learning,
and this effect is absent if the study–test interval is extended to 4 d
(Murchison et al., 2004). The modulation of emotional memory
by propranolol in humans may, therefore, also be time depen-
dent. Thus, a second explanation for the discrepancy between our
findings and a previous study (Tollenaar et al., 2009) might re-
flect the difference in study–test interval. This previous study,
which found no effect of propranolol administration on emo-
tional memory retrieval, tested retrieval 1 week after initial learn-
ing (Tollenaar et al., 2009) compared with the delay interval used
here of 24 h. It will be of interest to test whether the effect of
propranolol observed in the current study is still observed if
memory is tested4 d after learning.
A critical question pertains to the neurobiological basis for the
dependency of emotional episodic memory retrieval on the
-adrenergic system. The current data do not directly address
this, but potential explanations include the requirement for a
cue-evoked phasic rise in NE (Aston-Jones and Cohen, 2005)
such that there is congruence betweenNE signals at encoding and
retrieval (Morris et al., 1977). Alternatively, the emotional mem-
ory trace may be dependent on tonic noradrenergic input
(Murchison et al., 2004; Zhang et al., 2005) such that engagement
of -adrenergic receptors is essential for retrieval. It is conceiv-
able that tonic NE input is no longer required after completion of
systems level consolidation (Marr, 1970), which concords with a
time-limited role of NE in emotional memory retrieval derived
from animal data (Murchison et al., 2004).
In terms of a neuroanatomical basis for the effects we observe,
neuroimaging studies demonstrate amygdala involvement in
emotional memory retrieval. Amygdala activity has been re-
ported during retrieval of neutral stimuli previously encoded in
an emotional context (Maratos et al., 2001; Phelps et al., 2001;
Smith et al., 2004; Fenker et al., 2005). The amygdalamay directly
support emotional memory retrieval or could achieve this
through hippocampal modulation. Increased hippocampal–
amygdala coupling during retrieval of information encoded in an
emotional context has been demonstrated in human (Smith et al.,
2006) and rodent (Seidenbecher et al., 2003) studies. We suggest,
therefore, that the effects we observe result from a propra-
nolol-evoked disruption of amygdala responses, or hippocam-
pal–amygdala coupling.
Animal studies have provided evidence for amore general role
of NE in retrieval (Sara and Devauges, 1988, 1989; Devauges and
Sara, 1991; Murchison et al., 2004). Specifically, increasing NE
activity through pharmacological manipulation or by stimula-
tion of the LC can restore forgotten spatial memory in rats (Sara
and Devauges, 1988, 1989), via engagement of -adrenergic re-
ceptors (Devauges and Sara, 1991). Thus, these studies extend the
influence of NE at retrieval to include nonemotional memories.
In contrast to this, the effect of propranolol in our task did not
extend to cued recall of neutral words or items that were percep-
tually distinct at encoding (see supplemental material, available
at www.jneurosci.org), which may reflect the essential nonverbal
nature of animal tasks or effective central propranolol concentra-
tions in human versus animal studies.
Our second main finding is that -adrenergic blockade at
retrieval leads to a sustained reduction of emotional memory
retrieval 24 h later. The neurobiological basis for this effect could
reflect a number of processes including a disruption of secondary
encoding (Nadel and Land, 2000), a disruption of reconsolida-
tion (Nader et al., 2000; Debiec and Ledoux, 2004), or an impair-
ment of lingering consolidation (Dudai and Eisenberg, 2004).
Secondary encoding is the process whereby, during every re-
trieval episode, retrieved mnemonic information, together with
incoming sensory information, is stored as a novel memory trace
(Nadel and Moscovitch, 1997). This results in the accumulation
of multiple, related, mnemonic traces of a single episode within a
slightly altered neuronal and experiential context, which together
aid the retrieval of an episode (Nadel and Moscovitch, 1997).
Thus, blocking enhanced recall of emotional stimuli on day 2
with propranolol may have prevented formation of a novel emo-
tional memory trace, expressed as absent emotional memory en-
hancement in this group on day 3.
Alternatively, impaired reconsolidation may account for, at
least in part, the memory effects observed on day 3. Reconsolida-
tion refers to the idea that, on reactivation, memories return to a
labile state and are once again sensitive to disruption (Nader et
al., 2000). It is also known that reconsolidation of emotional
memories is disrupted by blocking NE within the amygdala
(Debiec and Ledoux, 2004). The long-termmemory impairment
we observe on day 3 could be attributed to propranolol having
blocked reconsolidation of the episodic enhancement process. As
such, the mechanisms mediating the enhancement of memory
for emotional items might not have been expressed. Typically, in
reconsolidation experiments, memories need to be reactivated to
return to a labile state. However, in the case of amygdala process-
ing of fear information, there is evidence that fear memories can
undergo reconsolidation even if not expressed (Duvarci et al.,
2006). Thus, propranolol might have impaired the reconsolida-
tion of emotional items not remembered on day 2, reducing their
chance of memory retrieval on day 3.
The third possible explanation for our effects on day 3 is
propranolol-induced impaired lingering consolidation. The lin-
gering consolidation hypothesis posits that iterations of reactiva-
tion and stabilization of memory traces are an essential feature of
consolidation, which, in contradistinction to standard models of
consolidation, is not time limited (Dudai and Eisenberg, 2004).
Thememory effects observed on day 3 could, therefore, be attrib-
uted to a disruption of ongoing consolidation. However, an ar-
gument against this explanation is the absence of any difference
between propranolol and placebo groups on memory for emo-
tional items on day 3 that were not cued on day 2. Thus, the
neurobiological mechanisms underlying our second main find-
ing, that emotional memory impairment evoked by propranolol
on day 2 persists to day 3, are likely to be a failure of secondary
encoding, impaired reconsolidation, or a combination of these
processes. Thus, blocking enhanced recall of emotional stimuli
on day 2 with propranolol may have prevented formation of a
novel emotional memory trace, expressed as absent emotional
memory enhancement in this group on day 3.
The efficacy of pharmacological prevention of the acquisition
of memories for traumatic experiences is limited by practicality
(Pitman et al., 2002; Vaiva et al., 2003). The possibility of phar-
macologically modulating established emotional memory at re-
trieval we demonstrate here supports a potential therapeutic
approach of attenuating unwanted established emotional mem-
ories. Our data support recent clinical findings that propranolol
administration to PTSD patients, after memory reactivation, re-
duces physiological responses to a subsequent script-driven
trauma imagery session (Brunet et al., 2008). We extend these
findings of post-reactivation modulation of implicit measures of
emotional memory by propranolol (Brunet et al., 2008; Kindt et
al., 2009) by demonstrating specific attenuation of retrieval of
emotional episodicmemory, without an impact on neutralmem-
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ory. Thus, we provide a theoretical justification for the potential
application of propranolol in reducing retrieval of traumatic
memories that justify studies of clinical interventions with
-adrenergic antagonists during reactivation of traumatic mem-
ory in anxiety-related disorders.
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